BACKGROUND Polycystic ovary syndrome (PCOS) is the most common cause of
anovulatory infertility. An endometrial component has been suggested to contribute to …

Polycystic ovary syndrome (PCOS) is the most common gynecological endocrine disorders
affecting up to 10% of all females in their reproductive age, and its cause of onset is still …

Context Antimüllerian hormone (AMH) levels are higher in patients with polycystic ovary
syndrome (PCOS). Accumulating evidence indicates that AMH has an impact on the …

The Mullerian ducts are the anlagen of the female reproductive tract, which regress in the
male fetus in response to MIS. This process is driven by subluminal mesenchymal cells …

Objective To correlate the distinct diagnostic criteria of polycystic ovary syndrome (PCOS)
with the development of maternal and neonatal complications. Design Systematic review …

Context Anti-Müllerian hormone (AMH) levels are increased in polycystic ovary syndrome
(PCOS) patients and are associated with PCOS severity. Objective To evaluate the …

Objective To explore whether elevated anti-Müllerian hormone (AMH) levels affect the rate
of preterm birth (PTB) among PCOS patients with different BMIs. Methods In this …

Objective To determine the relationship between high antimüllerian hormone (AMH) levels
and increased preterm delivery risk in populations of women with polycystic ovary syndrome …

Purpose To enhance the understanding of the clinical significance of anti-Müllerian
hormone (AMH) in follicular fluid, we aimed to determine the variability of AMH …

Objective To assess anti‐Müllerian hormone (AMH) levels as a marker of early abortion in
the first trimester among women younger than 35 years. Methods Prospective study of …